ADAPTIVE BIOTECHNOLOGIES COR's ticker is ADPT and the CUSIP is 00650F109. A total of 223 filers reported holding ADAPTIVE BIOTECHNOLOGIES COR in Q4 2022. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $308,971 | -15.8% | 56,692 | +3.7% | 0.00% | 0.0% |
| Q2 2023 | $366,876 | -22.8% | 54,676 | +1.6% | 0.00% | -33.3% |
| Q1 2023 | $475,142 | +17.9% | 53,810 | +2.0% | 0.00% | 0.0% |
| Q4 2022 | $402,926 | +6.9% | 52,739 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $377,000 | -10.7% | 52,930 | +1.4% | 0.00% | 0.0% |
| Q2 2022 | $422,000 | +1463.0% | 52,183 | +2555.6% | 0.00% | – |
| Q1 2022 | $27,000 | -50.9% | 1,965 | -0.1% | 0.00% | – |
| Q4 2021 | $55,000 | -20.3% | 1,967 | -3.4% | 0.00% | – |
| Q3 2021 | $69,000 | -23.3% | 2,036 | -7.3% | 0.00% | – |
| Q2 2021 | $90,000 | +30.4% | 2,197 | +28.6% | 0.00% | – |
| Q1 2021 | $69,000 | -38.9% | 1,709 | -10.7% | 0.00% | – |
| Q4 2020 | $113,000 | +16.5% | 1,914 | -4.0% | 0.00% | – |
| Q3 2020 | $97,000 | +3.2% | 1,994 | +2.5% | 0.00% | – |
| Q2 2020 | $94,000 | +141.0% | 1,946 | +39.8% | 0.00% | – |
| Q1 2020 | $39,000 | +290.0% | 1,392 | +300.0% | 0.00% | – |
| Q4 2019 | $10,000 | -9.1% | 348 | -3.9% | 0.00% | – |
| Q3 2019 | $11,000 | – | 362 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,377,665 | $12,958,274 | 12.23% |
| Eagle Health Investments LP | 1,214,860 | $6,620,987 | 1.46% |
| Matrix Capital Management Company, LP | 11,572,590 | $63,070,616 | 0.76% |
| Aristotle Atlantic Partners, LLC | 3,058,206 | $16,667,223 | 0.67% |
| VIKING GLOBAL INVESTORS LP | 29,993,708 | $163,465,709 | 0.66% |
| Pier Capital, LLC | 719,067 | $3,918,915 | 0.63% |
| DDD Partners, LLC | 783,697 | $3,385,571 | 0.49% |
| ARK Investment Management | 11,509,308 | $62,725,728 | 0.48% |
| Nikko Asset Management Americas, Inc. | 6,570,939 | $35,680,199 | 0.43% |
| Triatomic Management LP | 102,889 | $560,745 | 0.39% |